questionsmedicales.fr
Techniques d'investigation
Techniques immunologiques
Tests immunologiques
Tests sérologiques
Tests d'inhibition de l'hémadsorption
Tests d'inhibition de l'hémadsorption : Questions médicales fréquentes
Diagnostic
5
Tests de diagnostic
Hémadsorption
Infections virales
Virus
Infections virales
Hémadsorption
Précision des tests
Hémadsorption
Diagnostic
Infections virales
Tests de diagnostic
Épidémies
Sérum
Plasma
Tests de diagnostic
Symptômes
5
Symptômes
Infections virales
Fièvre
Symptômes
Virus
Infections virales
Évolution des symptômes
Infections virales
Surveillance médicale
Infections asymptomatiques
Symptômes
Diagnostic
Signes cliniques
Urgences médicales
Infections virales
Prévention
5
Prévention
Hygiène
Vaccins
Hygiène
Prévention
Infections virales
Masques
Prévention
Transmission virale
Voyages
Infections virales
Prévention
Désinfectants
Prévention
Infections virales
Traitements
5
Antiviraux
Traitements
Infections virales
Antibiotiques
Infections virales
Traitements
Antiviraux
Mécanisme d'action
Infections virales
Repos
Système immunitaire
Infections virales
Vaccins
Prévention
Infections virales
Complications
5
Complications
Infections virales
Pneumonie
Complications
Infections virales
État de santé
Prévention
Traitement précoce
Complications
Personnes âgées
Complications
Infections virales
Traitement
Complications
Infections virales
Facteurs de risque
5
Facteurs de risque
Infections virales
Immunodépression
Mode de vie
Facteurs de risque
Prévention
Maladies chroniques
Facteurs de risque
Infections virales
Stress
Système immunitaire
Facteurs de risque
Voyages
Facteurs de risque
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tests d'inhibition de l'hémadsorption : Questions médicales les plus fréquentes",
"headline": "Tests d'inhibition de l'hémadsorption : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tests d'inhibition de l'hémadsorption : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-05",
"dateModified": "2026-02-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tests d'inhibition de l'hémadsorption"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tests sérologiques",
"url": "https://questionsmedicales.fr/mesh/D012698",
"about": {
"@type": "MedicalCondition",
"name": "Tests sérologiques",
"code": {
"@type": "MedicalCode",
"code": "D012698",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.478.594.760"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tests d'inhibition de l'hémadsorption",
"alternateName": "Hemadsorption Inhibition Tests",
"code": {
"@type": "MedicalCode",
"code": "D006383",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Salvatore Lucio Cutuli",
"url": "https://questionsmedicales.fr/author/Salvatore%20Lucio%20Cutuli",
"affiliation": {
"@type": "Organization",
"name": "Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS."
}
},
{
"@type": "Person",
"name": "Massimo Antonelli",
"url": "https://questionsmedicales.fr/author/Massimo%20Antonelli",
"affiliation": {
"@type": "Organization",
"name": "Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS."
}
},
{
"@type": "Person",
"name": "Suna Koc",
"url": "https://questionsmedicales.fr/author/Suna%20Koc",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Harun Uysal",
"url": "https://questionsmedicales.fr/author/Harun%20Uysal",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tatyana M Timiryasova",
"url": "https://questionsmedicales.fr/author/Tatyana%20M%20Timiryasova",
"affiliation": {
"@type": "Organization",
"name": "Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: tatyana.timiryasova@sanofi.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Hemadsorption in Critically Ill Children.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37263250",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000529904"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hemadsorption extracorporeal therapy removes cytokines ex vivo in horses.",
"datePublished": "2024-03-18",
"url": "https://questionsmedicales.fr/article/38484466",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2460/ajvr.24.01.0022"
}
},
{
"@type": "ScholarlyArticle",
"name": "A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy.",
"datePublished": "2023-12-12",
"url": "https://questionsmedicales.fr/article/38084784",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/sdi.13188"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of extracorporeal hemadsorption on mortality in critically ill COVID-19 patients in the intensive care unit.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39268922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03913988241269527"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients.",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/38776889",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000539396"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques immunologiques",
"item": "https://questionsmedicales.fr/mesh/D007158"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tests immunologiques",
"item": "https://questionsmedicales.fr/mesh/D007159"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tests sérologiques",
"item": "https://questionsmedicales.fr/mesh/D012698"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tests d'inhibition de l'hémadsorption",
"item": "https://questionsmedicales.fr/mesh/D006383"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tests d'inhibition de l'hémadsorption - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tests d'inhibition de l'hémadsorption",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tests d'inhibition de l'hémadsorption",
"description": "Comment fonctionne un test d'inhibition de l'hémadsorption ?\nQuels pathogènes sont détectés par ce test ?\nQuelle est la précision de ces tests ?\nQuand utiliser ce test dans un diagnostic ?\nQuels échantillons sont nécessaires pour le test ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tests d'inhibition de l'hémadsorption",
"description": "Quels symptômes indiquent une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils ?\nLes symptômes sont toujours présents lors d'une infection ?\nQuels signes cliniques sont alarmants ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tests d'inhibition de l'hémadsorption",
"description": "Comment prévenir les infections virales ?\nLe lavage des mains est-il efficace ?\nLes masques aident-ils à prévenir la transmission ?\nLes voyages augmentent-ils le risque d'infection ?\nLes désinfectants sont-ils efficaces contre les virus ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tests d'inhibition de l'hémadsorption",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLe repos est-il important lors d'une infection ?\nLes vaccins peuvent-ils prévenir ces infections ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tests d'inhibition de l'hémadsorption",
"description": "Quelles complications peuvent survenir avec une infection virale ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?\nLes personnes âgées sont-elles plus à risque ?\nLes complications peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tests d'inhibition de l'hémadsorption",
"description": "Quels sont les principaux facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nLe stress a-t-il un impact sur le risque d'infection ?\nLes voyages fréquents augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D006383#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment fonctionne un test d'inhibition de l'hémadsorption ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il mesure la capacité d'un agent à empêcher l'adsorption des globules rouges par des pathogènes."
}
},
{
"@type": "Question",
"name": "Quels pathogènes sont détectés par ce test ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Principalement des virus comme la grippe, le VIH et certains virus hématotropes."
}
},
{
"@type": "Question",
"name": "Quelle est la précision de ces tests ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La précision varie selon le pathogène et le protocole, mais ils sont généralement fiables."
}
},
{
"@type": "Question",
"name": "Quand utiliser ce test dans un diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé lorsque des infections virales sont suspectées, surtout en cas d'épidémies."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont nécessaires pour le test ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de sérum ou de plasma sont généralement requis pour l'analyse."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et symptômes respiratoires sont courants."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques, mais certains sont communs."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver rapidement, nécessitant une surveillance médicale attentive."
}
},
{
"@type": "Question",
"name": "Les symptômes sont toujours présents lors d'une infection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certaines infections peuvent être asymptomatiques, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont alarmants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficulté respiratoire, confusion, ou déshydratation nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, se faire vacciner et éviter les contacts étroits."
}
},
{
"@type": "Question",
"name": "Le lavage des mains est-il efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un lavage régulier des mains réduit significativement le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir la transmission ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la propagation des virus, surtout dans les lieux bondés."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus, surtout dans des zones à risque."
}
},
{
"@type": "Question",
"name": "Les désinfectants sont-ils efficaces contre les virus ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les désinfectants à base d'alcool peuvent tuer de nombreux virus sur les surfaces."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antiviraux, soins de soutien et parfois des traitements spécifiques selon le virus."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne traitent que les infections bactériennes, pas virales."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant la gravité et la durée de l'infection."
}
},
{
"@type": "Question",
"name": "Le repos est-il important lors d'une infection ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos aide le système immunitaire à combattre l'infection plus efficacement."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir ces infections ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins sont efficaces pour prévenir des infections virales spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pneumonie, déshydratation, et complications neurologiques sont possibles."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles varient selon le virus et l'état de santé du patient, mais peuvent être graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et un suivi médical peuvent aider à éviter les complications."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un risque accru de complications graves lors d'infections virales."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être traitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais cela dépend de leur nature et gravité."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, immunodépression, et conditions médicales préexistantes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain avec une bonne nutrition et exercice réduit le risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies cardiaques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affaiblir le système immunitaire, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les voyages fréquents augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager expose à de nouveaux agents pathogènes, augmentant le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/02/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Facoltà di Medicina e Chirurgia 'A. Gemelli', Università Cattolica del Sacro Cuore, Rome, Italy.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: tatyana.timiryasova@sanofi.com.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: lingyi.zheng@sanofi.com.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: amy.singer@sanofi.com.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: celine.petit@sanofi.com.
Publications dans "Tests d'inhibition de l'hémadsorption" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18370, USA. Electronic address: monique.brown@sanofi.com.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Federal Research Center for Virology and Microbiology (FRCVM), Volginskiy, Russia. amalogolovkin@vniivvim.ru.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Federal Research Center for Virology and Microbiology (FRCVM), Volginskiy, Russia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Unità Operativa Complessa di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica; Dipartimento di Scienze dell'Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Facoltà di Medicina e Chirurgia 'A. Gemelli', Università Cattolica del Sacro Cuore, Rome, Italy.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Clinical Department of Anaesthesiology and Perioperative Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Clinical Department of Anaesthesiology and Perioperative Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia.
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Clinical Department of Anaesthesiology and Perioperative Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Clinical Department of Anaesthesiology and Perioperative Intensive Therapy, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
University of Ljubljana, Faculty of Computer and Information Science, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
1 publication dans cette catégorie
Affiliations :
University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia.
Publications dans "Tests d'inhibition de l'hémadsorption" :
Application of extracorporeal blood purification in children is increasing with the improvement of technology and the broadening of indications in critically ill patients. Furthermore, novel devices a...
Plasma cytokine adsorption has shown benefit as an adjunctive therapy in human sepsis but has yet to be investigated in horses. We hypothesized that ex vivo filtration of equine plasma with a novel cy...
8 horses owned by North Carolina State University....
Four liters of heparinized whole blood was collected from healthy adult horses (n = 8) and stimulated with lipopolysaccharide (100 ng/mL) for 6 hours (37 °C.) from June 4, 2023, to December 15, 2023. ...
Filtration of lipopolysaccharide-stimulated equine plasma (n = 8) for 6 hours resulted in significant mean reductions in the cytokines IL-10, IL-5, IL-8, tumor necrosis factor-α (TNF-α), and IL-1β, as...
This work provides proof of concept for further investigation of extracorporeal cytokine adsorption as a potential adjunct treatment for equine sepsis....
Infectious diseases are among the most common cause of morbidity and mortality among hospitalized patients while systemic inflammatory response syndrome is primarily attributed to the imbalance betwee...
The consequences of COVID-19, such as respiratory failure and mortality, require the search for fast and effective solutions. The aim of this retrospective study is to determine the effect of extracor...
Our study is retrospective, single-center, and observational. The study included ICU patients diagnosed with COVID-19 who received extracorporeal hemadsorption treatment between March 2020 and Decembe...
Seventeen patients were included in the study. The mortality rate in the study was 64.7%. After hemadsorption, an increase was observed in the lymphocyte numbers, APACHE-II, and SOFA values of the pat...
In COVID-19 patients, APACHE-II and SOFA scores may be useful in predicting the effectiveness of extracorporeal hemadsorption. Our study found that patients with higher APACHE-II and SOFA scores at ba...
Combined hemodialysis (HD) and hemadsorption (HA) therapy has shown the highest clearance rates for middle and large-sized uremic toxin molecules and reduced mortality rates among maintenance HD (MHD)...
Forty patients with end-stage renal disease (ESRD) were divided into three groups: HD only (14), HD+biweekly HA (14), and HD+weekly HA (12). The duration of the study was 8 weeks. Uremic toxins (β2-mi...
Decrease in BUN level (-61.34 mg/dL [95% CI:-71.33 to -51.34], p <0.0001) and pruritus score (-3.93 [95% CI:-6.89 to -0.97], p=0.013) was significantly larger in HD+biweekly HA group compared to th...
HD combined with a biweekly HA is associated with a greater reduction in BUN level and better improvement of pruritus in ESRD patients compared to HD alone. HD+biweekly HA can significantly reduce CRP...
African swine fever virus (ASFV) is the cause of African swine fever (ASF), a devastating disease that affects domestic pigs and wild boar and is currently responsible for the largest animal epidemic....
Polymyxin B hemadsorption (PMX-HA) reduces blood endotoxin levels, but characteristics of patients with sepsis likely to benefit from PMX-HA are not well known. We sought to identify patient subgroups...
We retrospectively identified 1911 patients with sepsis from a retrospective observational study in Japan (the JSEPTIC-DIC study) and 286 patients with endotoxemic septic shock from a randomized contr...
The causal forest model revealed heterogeneity in treatment effects of PMX-HA. Since patients having higher treatment effects were more likely to have severe coagulopathy and hyperlactatemia, we ident...
Abnormal coagulation and hyperlactatemia in septic patients with high endotoxin activity appear to be helpful to identify patients who may benefit most from PMX-HA. Our findings will inform enrollment...
Cardiogenic shock and arrest present as critical, life-threatening emergencies characterized by severely compromised tissue perfusion and inadequate oxygen supply. Veno-arterial extracorporeal membran...
ECMOsorb is a single-center, controlled, randomized, triple-blinded trial that will compare the hemodynamic effects of treatment with a VA-ECMO in combination with a cytokine adsorber (CytoSorb...
The ECMOsorb trial seeks to assess the efficacy of a cytokine adsorber (CytoSorb...
Ecotoxicity data on cellulose nanofibers (CNFs) are limited despite their wide potential applications prospects, such as structural and packaging materials, filters, coatings, foods, and cosmetics. In...
The presence of polymerase-chain-reaction (PCR) inhibitors in many environmental samples can make reliable and repeatable quantitative-polymerase-chain-reaction (qPCR) analysis difficult without sampl...